Home / Human Menopausal Gonadotrophin / Norway
NO ATC G03GA02 · updated 2 Nov 2026
Human Menopausal Gonadotrophin shortage in Norway
Is there a Human Menopausal Gonadotrophin shortage in Norway?
Yes. As of 2 Nov 2026, 2 Human Menopausal Gonadotrophin products are reported short in Norway, the first since 17 Jan 2025. The company estimate for the return is 31 Aug 2027. Main reason: regulatory or licensing.
Also short in Belgium, Czechia, Sweden, Japan. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Menopur 600 IU injeksjonsvæske, oppløsning i ferdigfylt penn, 1 stk ferdigfylt penn | Ferring Legemidler As | 17 Jan 2025 | 31 Aug 2027 | Regulatory or licensing Regulatoriske problemer |
| NO | Menopur 1 200 IU injeksjonsvæske, oppløsning i ferdigfylt penn, 1 stk ferdigfylt penn | Ferring Legemidler As | 14 Feb 2025 | 31 Aug 2027 | Regulatory or licensing Regulatoriske problemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).